跳到正文
登录

公司

Minghui Pharmaceutical

打开结构图

Minghui Pharmaceutical 的结构

Minghui Pharmaceutical

公司

3 个关联
上游供应与依赖
同行竞争与合作
关系出现时间2026
Minghui Pharmaceutical公司 · 3 个关联
第 1 层

上游供应与依赖2

同行竞争与合作1

在关系网络中的位置

第 15082 位,共 118934 个前 13%本周下降 7912 位

3 条直接关系

按有证据的公开关系计算,每天更新。

关系

箭头表示关系方向,可按业务类别筛选。

  • Minghui Pharmaceutical签署协议 →ASKA Pharmaceutical Co., Ltd.
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-11-04 14:30
      Minghui Pharmaceutical ("Minghui") and ASKA Pharmaceutical Co., Ltd. ("ASKA") today announced that they have entered into an exclusive license agreement for the development and commercialization of MHB018A in Japan.
      查看来源
  • Stifel服务于 →Minghui Pharmaceutical
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-11-04 14:30
      Stifel is serving as exclusive financial advisor to Minghui
      查看来源
  • Fangda Partners服务于 →Minghui Pharmaceutical
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-11-04 14:30
      Fangda Partners is serving as legal advisor.
      查看来源

显示第 1 至 3 条,共 3 条

结论

结合来源阅读结论,展开条目查看证据。

事实证据 1
服务于Stifel

Stifel is serving as exclusive financial advisor to Minghui

PR Newswire news releases · 2026-11-04 14:30

查看证据
  • 公司披露PR Newswire news releases2026-11-04 14:30
    Stifel is serving as exclusive financial advisor to Minghui
    查看来源
事实证据 1

Fangda Partners is serving as legal advisor.

PR Newswire news releases · 2026-11-04 14:30

查看证据
  • 公司披露PR Newswire news releases2026-11-04 14:30
    Fangda Partners is serving as legal advisor.
    查看来源
事实证据 1

Minghui Pharmaceutical ("Minghui") and ASKA Pharmaceutical Co., Ltd. ("ASKA") today announced that they have entered into an exclusive license agreement for the development and commercialization of MHB018A in Japan.

PR Newswire news releases · 2026-11-04 14:30

查看证据
  • 公司披露PR Newswire news releases2026-11-04 14:30
    Minghui Pharmaceutical ("Minghui") and ASKA Pharmaceutical Co., Ltd. ("ASKA") today announced that they have entered into an exclusive license agreement for the development and commercialization of MHB018A in Japan.
    查看来源
事实证据 1
upfront payment110 USD million

Minghui will receive an upfront payment of USD 110 million

PR Newswire news releases · 2026-11-04 14:30

查看证据
  • 公司披露PR Newswire news releases2026-11-04 14:30
    Minghui will receive an upfront payment of USD 110 million
    查看来源
事实证据 1
tiered royalties on net sales in japan up tomid-30%

as well as tiered royalties up to mid-30% on net sales in Japan.

PR Newswire news releases · 2026-11-04 14:30

查看证据
  • 公司披露PR Newswire news releases2026-11-04 14:30
    as well as tiered royalties up to mid-30% on net sales in Japan.
    查看来源

显示第 1 至 5 条,共 5 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

推荐一个值得监测的页面

这家公司有哪些页面值得盯着,比如价格、更新日志、条款或招聘页?推荐给我们。每条推荐都有人看;收录后,这个页面会为所有读者一起监测,并且只有连续两次抓取一致才算一次变化。

登录后推荐页面

暂无: 公司信号 · 财务数据 · 披露文件 · 据点 · 业绩指引